Literature DB >> 1319475

The treatment of adult supratentorial high grade astrocytomas.

G G Duncan1, G B Goodman, C M Ludgate, D E Rheaume.   

Abstract

From 1 January, 1982 until 31 December, 1987 260 adult patients were referred to the Cancer Control Agency of B.C. with high grade supratentorial astrocytomas. Multifocal disease on presentation was present in 17 cases (6.5%). Their survival is poor and whole brain radiotherapy is required. All other cases had unifocal disease, but eight did not receive radiotherapy. The 235 cases who received radiotherapy were subject to univariate and multivariate analyses according to extent of surgery, age, Kernohan and WHO grading, Karnofsky performance status, whole brain treatment, partial brain treatment, total dose and neuroret. Age is an extremely important predictor of survival (P approximately equal to 0). The pathologic appearance of glioblastoma (WHO grade) as well as the Karnofsky performance status were also important independent factors in predicting survival (P = 0.016, 0.027 respectively) on Cox multivariate analysis. Dose and neurorets were significant factors only in cases where the performance status was not recorded, suggesting that dose was selected according to the patient's condition and age. In this analysis it was found that localized radiation fields may be used rather than whole brain without jeopardizing survival.

Entities:  

Mesh:

Year:  1992        PMID: 1319475     DOI: 10.1007/bf00172947

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Radiation therapy in the treatment of glioblastoma.

Authors:  Y Onoyama; M Abe; E Yabumoto; T Sakamoto; T Nishidai
Journal:  AJR Am J Roentgenol       Date:  1976-03       Impact factor: 3.959

2.  Superfractionated radiotherapy in grade III, IV intracranial gliomas.

Authors:  C M Ludgate; B G Douglas; P F Dixon; P Steinbok; S M Jackson; G B Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-11       Impact factor: 7.038

Review 3.  The fallacy of the localized supratentorial malignant glioma.

Authors:  E C Halperin; P C Burger; D E Bullard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

4.  Radiotherapy of glioblastoma multiforme.

Authors:  R G Ramsey; W N Brand
Journal:  J Neurosurg       Date:  1973-08       Impact factor: 5.115

5.  Tumor extent as a determining factor in radiotherapy of glioblastomas.

Authors:  S Kramer
Journal:  Acta Radiol Ther Phys Biol       Date:  1969 Feb-Apr

6.  Brain tolerance unit: a method to estimate risk of radiation brain injury for various dose schedules.

Authors:  R D Pezner; J O Archambeau
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-03       Impact factor: 7.038

7.  Patterns of failure in intracranial astrocytomas after irradiation: analysis of dose and field factors.

Authors:  O M Salazar; P Rubin; J V McDonald; M L Feldstein
Journal:  AJR Am J Roentgenol       Date:  1976-02       Impact factor: 3.959

8.  Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

Authors:  P C Burger; P J Dubois; S C Schold; K R Smith; G L Odom; D C Crafts; F Giangaspero
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

9.  Assumptions in the radiotherapy of glioblastoma.

Authors:  F H Hochberg; A Pruitt
Journal:  Neurology       Date:  1980-09       Impact factor: 9.910

10.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

View more
  8 in total

1.  The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.

Authors:  S L Hwang; Y H Yang; A S Lieu; M C Chuang; S J Chang; Y Y Chang; H J Lin; S L Howng
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 2.  Operative techniques for gliomas and the value of extent of resection.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Maximizing safe resection of low- and high-grade glioma.

Authors:  Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  J Neurooncol       Date:  2016-05-12       Impact factor: 4.130

Review 4.  The value of extent of resection of glioblastomas: clinical evidence and current approach.

Authors:  Joao Paulo Almeida; Kaisorn L Chaichana; Jordina Rincon-Torroella; Alfredo Quinones-Hinojosa
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

5.  The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30.

Authors:  J Schaafsma; D Osoba
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

Review 6.  Management and treatment recommendations for World Health Organization Grade III and IV gliomas.

Authors:  Abdullah K Altwairgi; Shanker Raja; Mohammed Manzoor; Sadeq Aldandan; Eyad Alsaeed; Ali Balbaid; Hussain Alhussain; Yassir Orz; Ahmed Lary; Abdullah A Alsharm
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jul-Sep

7.  The value of glioma extent of resection in the modern neurosurgical era.

Authors:  Douglas A Hardesty; Nader Sanai
Journal:  Front Neurol       Date:  2012-10-18       Impact factor: 4.003

8.  Outcome of patients with glioblastoma in Saudi Arabia: Single center experience.

Authors:  Abdullah K Altwairgi; Waleed Algareeb; Gaaem Yahya; Ahmed M Maklad; Moamen Mom Aly; Wafa Al Shakweer; Ali Balbaid; Eyad Alsaeed; Hussain Alhussain; Yassir Orz; Ahmed Lary; Ashraf Elyamany
Journal:  Mol Clin Oncol       Date:  2016-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.